Literature DB >> 32203199

Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations.

Isis B T Joosten1,2, Debby M E I Hellebrekers3, Bianca T A de Greef1,2,4, Hubert J M Smeets2,5,6, Christine E M de Die-Smulders3, Catharina G Faber1,2, Monique M Gerrits7.   

Abstract

Myotonic dystrophy type 1 (DM1) is caused by a CTG trinucleotide repeat expansion on chromosome 19q13.3. While DM1 premutation (36-50 repeats) and protomutation (51-80 repeats) allele carriers are mostly asymptomatic, offspring is at risk of inheriting expanded, symptom-associated, (CTG)n repeats of n > 80. In this study we aimed to evaluate the intergenerational instability of DM1 pre- and protomutation alleles, focussing on the influence of parental gender. One hundred and forty-six parent-child pairs (34 parental premutations, 112 protomutations) were retrospectively selected from the DM1 patient cohort of the Maastricht University Medical Center+. CTG repeat size of parents and children was determined by (triplet-primed) PCR followed by fragment length analysis and Southern blot analysis. Fifty-eight out of eighty-one (71.6%) paternal transmissions led to a (CTG)n repeat of n > 80 in offspring, compared with 15 out of 65 (23.1%) maternal transmissions (p < 0.001). Repeat length instability occurred for paternal (CTG)n repeats of n ≥ 45, while maternal instability did not occur until (CTG)n repeats reached a length of n ≥ 71. Transmission of premutations caused (CTG)n repeats of n > 80 in offspring only when paternally transmitted (two cases), while protomutations caused (CTG)n repeats of n > 80 in offspring in 71 cases, of which 56 (78.9%) were paternally transmitted. In conclusion, our data show that paternally transmitted pre- and protomutations were more unstable than maternally transmitted pre- and protomutations. For genetic counseling, this implies that males with a small DMPK mutation have a higher risk of symptomatic offspring compared with females. Consequently, we suggest addressing sex-dependent factors in genetic counseling of small-sized CTG repeat carriers.

Entities:  

Mesh:

Year:  2020        PMID: 32203199      PMCID: PMC7316980          DOI: 10.1038/s41431-020-0601-4

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  39 in total

Review 1.  Diseases of unstable repeat expansion: mechanisms and common principles.

Authors:  Jennifer R Gatchel; Huda Y Zoghbi
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

2.  Detection of a premutation in Japanese myotonic dystrophy.

Authors:  H Yamagata; T Miki; S Sakoda; N Yamanaka; J Davies; P Shelbourne; R Kubota; S Takenaga; M Nakagawa; T Ogihara
Journal:  Hum Mol Genet       Date:  1994-05       Impact factor: 6.150

3.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

4.  Myotonic dystrophy CTG repeats and the associated insertion/deletion polymorphism in human and primate populations.

Authors:  D C Rubinsztein; J Leggo; W Amos; D E Barton; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1994-11       Impact factor: 6.150

5.  Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats.

Authors:  A Goldman; M Ramsay; T Jenkins
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

6.  Normal variation at the myotonic dystrophy locus in global human populations.

Authors:  C Zerylnick; A Torroni; S L Sherman; S T Warren
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 7.  Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Biochim Biophys Acta       Date:  2014-05-29

8.  Origin of the expansion mutation in myotonic dystrophy.

Authors:  G Imbert; C Kretz; K Johnson; J L Mandel
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

9.  High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.

Authors:  C E Neville; M S Mahadevan; J M Barceló; R G Korneluk
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

10.  Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.

Authors:  Erik-Jan Kamsteeg; Wolfram Kress; Claudio Catalli; Jens M Hertz; Martina Witsch-Baumgartner; Michael F Buckley; Baziel G M van Engelen; Marianne Schwartz; Hans Scheffer
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

View more
  4 in total

Review 1.  Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences.

Authors:  Terence Gall-Duncan; Nozomu Sato; Ryan K C Yuen; Christopher E Pearson
Journal:  Genome Res       Date:  2021-12-29       Impact factor: 9.438

2.  Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1.

Authors:  Ji Yoon Han; Woori Jang; Joonhong Park
Journal:  Genes (Basel)       Date:  2022-08-17       Impact factor: 4.141

3.  Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.

Authors:  Nicholas E Johnson; Russell J Butterfield; Katie Mayne; Tara Newcomb; Carina Imburgia; Diane Dunn; Brett Duval; Marcia L Feldkamp; Robert B Weiss
Journal:  Neurology       Date:  2021-01-20       Impact factor: 9.910

4.  Robust Detection of Somatic Mosaicism and Repeat Interruptions by Long-Read Targeted Sequencing in Myotonic Dystrophy Type 1.

Authors:  Antoine Mangin; Laure de Pontual; Yu-Chih Tsai; Laetitia Monteil; Mathilde Nizon; Pierre Boisseau; Sandra Mercier; Janet Ziegle; John Harting; Cheryl Heiner; Geneviève Gourdon; Stéphanie Tomé
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.